Your browser doesn't support javascript.
loading
Development of a target product profile for new glucose self-monitoring technologies for use in low- and middle-income countries.
Safary, Elvis; Lepeska, Molly; Beran, David; Ewen, Margaret; Zhaparova, Aigerim; Rukare, Jackie; Boulle, Philippa; Aebischer Perone, Sigiriya; Makohliso, Solomzi; Pleus, Stefan; Vetter, Beatrice.
Afiliação
  • Safary E; FIND, Geneva, Switzerland.
  • Lepeska M; Health Action International, Amsterdam, Netherlands.
  • Beran D; Division of Tropical and Humanitarian Medicine, University of Geneva and Geneva University Hospitals, Geneva, Switzerland.
  • Ewen M; Health Action International, Amsterdam, Netherlands.
  • Zhaparova A; Independent Consultant, Bishkek, Kyrgyzstan.
  • Rukare J; Independent Consultant, Kampala, Uganda.
  • Boulle P; Médecins Sans Frontiéres, Geneva, Switzerland.
  • Aebischer Perone S; Division of Tropical and Humanitarian Medicine, University of Geneva and Geneva University Hospitals, Geneva, Switzerland.
  • Makohliso S; International Committee of the Red Cross, Geneva, Switzerland.
  • Pleus S; Essential Tech Centre, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Vetter B; Institut für Diabetes Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.
PLoS One ; 19(8): e0309062, 2024.
Article em En | MEDLINE | ID: mdl-39186719
ABSTRACT

AIMS:

Most glucose self-monitoring devices have been developed with high-income countries in mind. We developed a target product profile (TPP) for new glucose self-monitoring technologies for users in low- and middle-income countries (LMICs).

METHODS:

A draft TPP including 39 characteristics was developed by an expert group including diabetes specialists, device specialists, and people with diabetes, incorporating findings from qualitative research in LMICs. Each characteristic had minimal and optimal requirements for two use cases, frequent and sporadic use. Characteristics requiring refinement were identified via online survey. Characteristics with agreement level <90% for any requirement were reviewed by the expert group and amended as appropriate.

RESULTS:

One characteristic (shelf life) had agreement <75% (both requirements for both use cases). Characteristics with agreement ≥75% and <90% for the frequent use case included infrastructure level, measurement cycle, duration of use before replacement, interchangeability, and calibration (both requirements), and activity log and price per month to end payer (minimal requirement). Intended use (both requirements), accuracy, and price per month to end payer (optimal requirement) had agreement ≥75% and <90% for the sporadic use case.

CONCLUSIONS:

This TPP will inform developers on requirements for glucose self-monitoring technologies for LMICs, and support decision-makers in evaluating existing devices.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Automonitorização da Glicemia / Países em Desenvolvimento Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Automonitorização da Glicemia / Países em Desenvolvimento Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça